Bringing the fundamentals into focus…
Back to Xeris Biopharma Holdings, Inc.
How Xeris Biopharma Holdings, Inc. stacks up
XERS · against 420 other Healthcare companies of similar size
Profitability
63/ 100
Above the middle of the pack.
Ranked #158 of 421 · scores higher than 61% of peers
Bars: peers in each 10-point band of the profitability score45 peers with a profitability score of 60–69, including XERS · Click a bar to see the companies
Why profitability scores 63?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its return on invested capital and operating margin, which are stronger than most Healthcare peers.
- a lower return on assets: weaker than 69% of peers. Return on assets: -4.2% vs peer median 1.7%
- a wider operating margin: stronger than 62% of peers. Operating margin: 10.9% vs peer median 7.1%
- a higher return on invested capital: stronger than 89% of peers. Return on invested capital: 23.9% vs peer median 4.7%
Metric by metric
Position: dot = XERS, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | XERS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 396 reported | 23.9% | 5.8% | 88% | 33% | |
| Operating marginHigher is better · 388 reported | 10.9% | 7.6% | 61% | 33% | |
| Return on assetsHigher is better · 404 reported | -4.2% | 2.0% | 27% | 33% | |
| Return on equityHigher is better · 389 reported | Not reported | 4.7% | — | — | Context only |
| Gross marginHigher is better · 435 reported | 86.6% | 47.6% | 92% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by profitability score
Top 5 and the companies ranked around XERS| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 4 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 4 | 11.2B DKK (≈$1.7B) | 99 | 59 | |
| 158 | 141.7B JPY (≈$963M) | 63 | 68 | |
| 158 | 16.3B CNY (≈$2.3B) | 63 | 49 | |
| 158 | 3.1B EUR (≈$3.4B) | 63 | 42 | |
| 158 | 1.6B GBP (≈$2.1B) | 63 | 67 | |
| 158 | 1.9B USD | 63 | 47 | |
| 166 | 11.0B CNY (≈$1.5B) | 62 | 57 | |
| 166 | 13.2B CNY (≈$1.9B) | 62 | 52 | |
| 168 | 22.8B CNY (≈$3.2B) | 61 | 60 | |
| 168 | 7.4B HKD (≈$949M) | 61 | 49 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score